Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 16.6
1.41 %
$ 766 M
Market Cap
-8.38
P/E
INCOME STATEMENT
675 M
REVENUE
87.7 M
OPERATING INCOME
42 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Pacira BioSciences, Inc.
| Revenue | 675 M |
| Cost Of Revenue | 185 M |
| Gross Profit | 490 M |
| Operating Expenses | 326 M |
| Operating Income | 87.7 M |
| Other Expenses | 45.7 M |
| Net Income | 42 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||
| Revenue | 675.0 | 666.8 | 541.5 | 420.8 | 421.0 | 337.3 | 286.6 | 276.4 | 249.0 | 197.7 | 85.6 | 39.1 | 15.7 | 14.6 | 15.0 | 13.9 |
| GROSS PROFIT | ||||||||||||||||
| Cost Of Revenue | 184.7 | 199.3 | 140.3 | 117.3 | 106.7 | 86.8 | 87.9 | 110.1 | 71.8 | 77.4 | 54.8 | 32.1 | 16.7 | 12.3 | 12.3 | 17.5 |
| Gross Profit | 490.3 | 467.5 | 401.3 | 303.5 | 314.3 | 250.4 | 198.7 | 166.3 | 177.2 | 120.2 | 30.8 | 6.9 | (1.1) | 2.3 | 2.7 | (3.5) |
| OPERATING INCOME | ||||||||||||||||
| Operating Expenses | 326.4 | 396.6 | 268.4 | 260.8 | 278.6 | 233.0 | 218.8 | 198.3 | 167.7 | 125.4 | 84.1 | 56.2 | 35.0 | 24.7 | 31.3 | 41.8 |
| Selling, General and Administrative Expenses | 269.4 | 254.5 | 199.3 | 193.5 | 200.8 | 177.3 | 161.5 | 152.6 | 139.0 | 106.7 | 62.5 | 46.3 | 20.2 | 6.0 | 5.0 | 8.6 |
| Research and Development Expenses | 76.3 | 84.8 | 55.5 | 59.4 | 72.1 | 55.7 | 57.3 | 45.7 | 28.7 | 18.7 | 21.6 | 9.9 | 14.9 | 18.6 | 26.2 | 33.2 |
| Operating Income | 87.7 | 60.0 | 131.1 | 46.4 | 38.1 | 15.9 | (24.9) | (32.0) | 9.5 | (5.2) | (53.3) | (49.3) | (39.1) | (22.4) | (28.5) | (45.4) |
| PRE-TAX INCOME | ||||||||||||||||
| Interest Income Expense | 20.3 | 40.0 | 31.8 | 25.7 | 23.6 | 21.9 | 18.0 | 7.1 | 7.7 | 8.3 | 7.3 | 1.8 | 4.8 | 4.9 | 3.6 | 3.5 |
| Total Other Income | (26.0) | (46.7) | (33.5) | (26.3) | (26.7) | (16.3) | (17.5) | (5.8) | (7.3) | (8.4) | (11.1) | (3.0) | (4.2) | (4.8) | (3.2) | 3.5 |
| Pre-Tax Income | 61.7 | 13.3 | 56.4 | 20.1 | (10.7) | (0.4) | (42.5) | (37.8) | 2.1 | (13.5) | (64.4) | (52.3) | (43.3) | (27.1) | (28.2) | (45.6) |
| NET INCOME | ||||||||||||||||
| Tax Provision | 19.7 | (2.6) | 14.4 | (125.4) | 0.3 | 46 K | 0.1 | 0.1 | 0.3 | 0.2 | (0.4) | (4.0) | 7.2 | 4.8 | 3.2 | (3.5) |
| Net Income | 42.0 | 15.9 | 42.0 | 145.5 | (11.0) | (0.5) | (42.6) | (37.9) | 1.9 | (13.7) | (63.9) | (52.3) | (43.3) | (27.1) | (31.7) | (41.9) |
| EPS | 0.91 | 0.35 | 0.95 | 3.41 | 0.27 | 0.0115 | 1.07 | 1.02 | 0.05 | 0.39 | 1.93 | 1.72 | 2.64 | 1.58 | 55.3 | 79.2 |